Results 211 to 220 of about 103,777 (248)

Radiotherapy Enhances the Oncolytic Efficacy of the Novel Oncolytic Herpesvirus VG161 and Amplifies Its Antitumor Immunity in Breast Cancer

open access: yesAdvanced Science, EarlyView.
RT promotes VG161 replication in BC and its immunostimulatory transgenes expression, which is mediated by the upregulation of GADD34 and HVEM caused by RT. The combination therapy with VG161 and RT increases the abundances of tumor‐infiltrating lymphocytes and elicits potent systemic antitumor immunity, thereby effectively inhibiting local tumors and ...
Lijuan Lyu   +13 more
wiley   +1 more source

FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3‐Mediated ErbB3 Fucosylation in Lung Adenocarcinoma

open access: yesAdvanced Science, EarlyView.
ABSTRACT While targeted therapies have improved outcomes in lung adenocarcinoma (LUAD), many patients still lack targetable mutations. Here, we identified alpha‐L‐fucosidase 2 (FUCA2) as a crucial driver of LUAD by preventing cellular senescence. Mechanistically, through the restriction of fucosyltransferase 3 (FUT3)‐mediated α‐1,3‐fucosylation of ...
Lu Chen   +18 more
wiley   +1 more source

Restoring Physiological Normoxia as an Adjuvant Strategy to Improve Cancer Treatment Outcomes. [PDF]

open access: yesNat Sci Sleep
Mas Bermejo C   +6 more
europepmc   +1 more source

Beyond antimicrobials: a host-directed precision pharmacotherapy framework for septic shock. [PDF]

open access: yesFront Med (Lausanne)
Cheng XZ   +6 more
europepmc   +1 more source

Towards host-directed therapies for tuberculosis [PDF]

open access: yesNature Reviews Drug Discovery, 2015
The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies.
Alimuddin Zumla   +2 more
exaly   +12 more sources

Host-directed Therapy: A New Arsenal to Come

Combinatorial Chemistry & High Throughput Screening, 2021
The emergence of drug-resistant strains among the variety of pathogens worsens the situation in today’s scenario. In such a situation, a very heavy demand for developing the new antibiotics has arisen, but unfortunately, very limited success has been achieved in this arena till now.
Mradul Mohan, Debapriya Bhattacharya
openaire   +2 more sources

Home - About - Disclaimer - Privacy